David L. Thomas

37.8k total citations · 8 hit papers
292 papers, 27.3k citations indexed

About

David L. Thomas is a scholar working on Hepatology, Epidemiology and Infectious Diseases. According to data from OpenAlex, David L. Thomas has authored 292 papers receiving a total of 27.3k indexed citations (citations by other indexed papers that have themselves been cited), including 244 papers in Hepatology, 228 papers in Epidemiology and 43 papers in Infectious Diseases. Recurrent topics in David L. Thomas's work include Hepatitis C virus research (241 papers), Hepatitis B Virus Studies (161 papers) and Liver Disease Diagnosis and Treatment (129 papers). David L. Thomas is often cited by papers focused on Hepatitis C virus research (241 papers), Hepatitis B Virus Studies (161 papers) and Liver Disease Diagnosis and Treatment (129 papers). David L. Thomas collaborates with scholars based in United States, India and China. David L. Thomas's co-authors include Leonard B. Seeff, Doris B. Strader, Mark Sulkowski, Marc G. Ghany, Shruti H. Mehta, David Vlahov, Chloe L. Thio, Michael Torbenson, Stuart C. Ray and Jacquie Astemborski and has published in prestigious journals such as Nature, Science and New England Journal of Medicine.

In The Last Decade

David L. Thomas

286 papers receiving 26.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Development of a simple noninvasive index to predict significant fibrosis in patients with HIV/HCV coinfection†‡

2006 3.5k citations Mark Sulkowski, David L. Thomas et al. profile →
Diagnosis, management, and treatment of hepatitis C: An update # † ‡

2008 2.3k citations Marc G. Ghany, David L. Thomas et al. profile →
Genetic variation in IL28B and spontaneous clearance of hepatitis C virus

2009 1.6k citations David L. Thomas, Chloe L. Thio et al. profile →
Diagnosis, management, and treatment of hepatitis C†

2004 1.3k citations David L. Thomas et al. profile →
HLA and NK Cell Inhibitory Receptor Genes in Resolving Hepatitis C Virus Infection

2004 906 citations Chloe L. Thio, Jacquie Astemborski et al. profile →
HIV-1, hepatitis B virus, and risk of liver-related mortality in the Multicenter Cohort Study (MACS)

2002 837 citations Chloe L. Thio, David L. Thomas et al. profile →
An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases

2011 828 citations Marc G. Ghany, David L. Thomas et al. profile →
Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023

2023 115 citations Erin E. Conners, Lakshmi Panagiotakopoulos et al. PubMed Central profile →

Peers

Countries citing papers authored by David L. Thomas

Since Specialization

Citations

This map shows the geographic impact of David L. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David L. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David L. Thomas more than expected).

Fields of papers citing papers by David L. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David L. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David L. Thomas. The network helps show where David L. Thomas may publish in the future.

Co-authorship network of co-authors of David L. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of David L. Thomas. A scholar is included among the top collaborators of David L. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David L. Thomas. David L. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Development of a Rapid Automated Point-of-Care Test for Hepatitis C Viral RNA on the DASH Rapid Polymerase Chain Reaction System 2025 ·The Journal of Infectious Diseases ·Jennifer L. Reed, (unknown), Claudia Hawkins, Yukari C. Manabe, (unknown), David L. Thomas, Andrea L. Cox, Sally M. McFall	1
2	Hepatitis B Virus DNA and RNA Persist in Liver After Serologic Recovery in Persons With Hepatitis C Virus 2024 ·The Journal of Infectious Diseases ·(unknown), David L. Thomas, Gregory D. Kirk, Shruti H. Mehta, Jacquie Astemborski, Georg M. Lauer, Ashwin Balagopal, Chloe L. Thio	1
3	Metagenomic next generation sequencing of plasma RNA for diagnosis of unexplained, acute febrile illness in Uganda 2024 ·PLoS neglected tropical diseases ·Abraham J. Kandathil, Paul W. Blair, Jennifer Lu, (unknown), (unknown), Matthew L. Robinson, (unknown), (unknown), J. Stephen Dumler, (unknown), Mohammed Lamorde, David L. Thomas, Steven L. Salzberg, Yukari C. Manabe	2
4	Hepatitis B Virus in People who Inject Drugs and Men who Have Sex With Men With HIV in India: A Cross-sectional Study 2024 ·Open Forum Infectious Diseases ·(unknown), (unknown), Hussain Syed Iqbal, Mark G. Anderson, Allison M. McFall, (unknown), Mary A. Rodgers, Aylur K. Srikrishnan, Ashwin Balagopal, Gregory M. Lucas, Shruti H. Mehta, David L. Thomas, Gavin Cloherty, Chloe L. Thio, Sunil S. Solomon	0
5	Two-Year Longitudinal Study Reveals That Long COVID Symptoms Peak and Quality of Life Nadirs at 6–12 Months Postinfection 2024 ·Open Forum Infectious Diseases ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jeffrey A. Tornheim, Paul W. Blair, Shruti H. Mehta, David L. Thomas, Yukari C. Manabe, Annukka A.R. Antar	16
6	Long-Read Nanopore-Based Sequencing of Anelloviruses 2024 ·Viruses ·(unknown), (unknown), Andrea L. Cox, Winston Timp, David L. Thomas, Steven J. Clipman, Abraham J. Kandathil	2
7	Screening and Testing for Hepatitis B Virus Infection: CDC Recommendations — United States, 2023 breakdown → 2023 ·PubMed Central ·Erin E. Conners, Lakshmi Panagiotakopoulos, Megan G. Hofmeister, Philip R. Spradling, Liesl M. Hagan, Aaron M. Harris, Jessica S. Rogers-Brown, C. William Wester, Noele P. Nelson, (unknown), (unknown), Amy L. Sandul, (unknown), Carla S. Coffin, Kristen Marks, David L. Thomas, Su H. Wang	115
8	Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Trial Design Considerations 2023 ·Clinical Infectious Diseases ·Jordan J. Feld, Julie Bruneau, Gregory J. Dore, Marc G. Ghany, Bettina E. Hansen, Mark Sulkowski, David L. Thomas	6
9	Controlled Human Infection Model for Hepatitis C Virus Vaccine Development: Is It Time to Be Real? 2023 ·Clinical Infectious Diseases ·T. Jake Liang, Jordan J. Feld, Naglaa H. Shoukry, David L. Thomas	1
10	Plasma virome and the risk of blood-borne infection in persons with substance use disorder 2021 ·Nature Communications ·Abraham J. Kandathil, Andrea L. Cox, Kimberly Page, David W. Mohr, Roham Razaghi, Khalil G. Ghanem, Susan Tuddenham, Yu‐Hsiang Hsieh, Jennifer L. Evans, Kelly E. Coller, Winston Timp, David D. Celentano, Stuart C. Ray, David L. Thomas	13
11	People with HIV-1 Demonstrate Type 1 Interferon Refractoriness Associated with Upregulated USP18 2021 ·Journal of Virology ·Sho K. Sugawara, Ramy El–Diwany, (unknown), (unknown), Christopher Y. K. Williams, Rebecca T. Veenhuis, Shruti H. Mehta, Joel N. Blankson, David L. Thomas, Andrea L. Cox, Ashwin Balagopal	6
12	Network‐based recruitment of people who inject drugs for hepatitis C testing and linkage to care 2020 ·Journal of Viral Hepatitis ·Oluwaseun Falade‐Nwulia, Kathleen Ward, (unknown), Shruti H. Mehta, Stephanie Pitts, (unknown), Geetanjali Chander, David L. Thomas, Mark Sulkowski, Carl A. Latkin	21
13	Sharing the cure: Building primary care and public health infrastructure to improve the hepatitis C care continuum in Maryland 2020 ·Journal of Viral Hepatitis ·Risha Irvin, (unknown), Mary B. Kleinman, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Lucy Wilson, Alexander J. Millman, Noele P. Nelson, Lauren Canary, Sherilyn Brinkley, Juhi Moon, Oluwaseun Falade‐Nwulia, Mark Sulkowski, David L. Thomas, Michael T. Melia	7
14	CMPK2 and BCL-G are associated with type 1 interferon–induced HIV restriction in humans 2018 ·Science Advances ·Ramy El–Diwany, Mary Soliman, Sho K. Sugawara, Florian P. Breitwieser, Alyza Skaist, (unknown), (unknown), Michael A. Chattergoon, Justin R. Bailey, Robert F. Siliciano, Joel N. Blankson, Stuart C. Ray, Sarah J. Wheelan, David L. Thomas, Ashwin Balagopal	50
15	Acute Hepatitis C Virus Infection Induces Consistent Changes in Circulating MicroRNAs That Are Associated with Nonlytic Hepatocyte Release 2015 ·Journal of Virology ·Ramy El–Diwany, Lisa N. Wasilewski, Kenneth W. Witwer, Justin R. Bailey, Kimberly Page, Stuart C. Ray, Andrea L. Cox, David L. Thomas, Ashwin Balagopal	17
16	Production of infectious genotype 1a hepatitis C virus (Hutchinson strain) in cultured human hepatoma cells 2006 ·Proceedings of the National Academy of Sciences ·MinKyung Yi, Rodrigo A. Villanueva, David L. Thomas, Takaji Wakita, Stanley M. Lemon	294
17	Genetic Protection against Hepatitis B Virus Conferred by CCR5Δ32 : Evidence that CCR5 Contributes to Viral Persistence 2006 ·Journal of Virology ·Chloe L. Thio, Jacquie Astemborski, Arman Bashirova, Timothy L. Mosbruger, (unknown), Mallory D. Witt, James J. Goedert, Margaret W. Hilgartner, Audrey J. Majeske, Stephen J. O’Brien, David L. Thomas, Mary Carrington	62
18	HIV/HCV coinfection: Comorbidity and clinical implications 2005 ·David L. Thomas	3
19	High Viral Load and Mild Liver Injury in Children with Hemophilia Compared with Other Children with Chronic Hepatitis C Virus Infection 1999 ·Journal of Pediatric Gastroenterology and Nutrition ·Aglaia Zellos, David L. Thomas, (unknown), Elizabeth J. Perlman, John K. Boitnott, James F. Casella, Kathleen B. Schwarz	1
20	High prevalence of hepatitis C in Egyptian patients with chronic liver disease. 1995 ·Gut ·Imam Waked, Sherif Saleh, (unknown), A Raouf, David L. Thomas, G. Thomas Strickland	70

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact